Brainstorm Cell Therapeutics Stock Performance
| BCLI Stock | USD 1.82 0.01 0.55% |
On a scale of 0 to 100, Brainstorm Cell holds a performance score of 3. The firm shows a Beta (market volatility) of -1.43, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Brainstorm Cell are expected to decrease by larger amounts. On the other hand, during market turmoil, Brainstorm Cell is expected to outperform it. Please check Brainstorm Cell's value at risk, rate of daily change, and the relationship between the total risk alpha and expected short fall , to make a quick decision on whether Brainstorm Cell's price patterns will revert.
Risk-Adjusted Performance
3 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Brainstorm Cell Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak essential indicators, Brainstorm Cell demonstrated solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor 1:15 | Last Split Date 2024-10-01 |
1 | BrainStorm Cell Therapeutics and Pluri Partner to Support NurOwn Phase 3b Trial Manufacturing - Yahoo Finance | 11/11/2024 |
2 | Acquisition by Arbel Irit of 25333 shares of Brainstorm Cell at 0.75 subject to Rule 16b-3 | 11/12/2024 |
3 | ARMISTICE CAPITAL, LLC Expands Stake in Brainstorm Cell Therapeutics Inc | 11/15/2024 |
4 | BrainStorm Strengthens Exosome Patent Portfolio Receives Notice of Allowance for U.S. Patent Covering Its Platform Technology | 12/03/2024 |
5 | Acquisition by Arbel Irit of 30666 shares of Brainstorm Cell subject to Rule 16b-3 | 12/31/2024 |
6 | Brainstorm Cell Therapeutics Appeals Nasdaq Delisting - MSN | 01/22/2025 |
| Begin Period Cash Flow | 772 K |
Brainstorm |
Brainstorm Cell Relative Risk vs. Return Landscape
If you would invest 180.00 in Brainstorm Cell Therapeutics on November 3, 2024 and sell it today you would earn a total of 2.99 from holding Brainstorm Cell Therapeutics or generate 1.66% return on investment over 90 days. Brainstorm Cell Therapeutics is currently generating 0.2991% in daily expected returns and assumes 7.611% risk (volatility on return distribution) over the 90 days horizon. In different words, 67% of stocks are less volatile than Brainstorm, and 95% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Brainstorm Cell Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Brainstorm Cell's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Brainstorm Cell Therapeutics, and traders can use it to determine the average amount a Brainstorm Cell's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0393
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BCLI | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 7.61 actual daily | 67 67% of assets are less volatile |
Expected Return
| 0.3 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 3 97% of assets perform better |
Based on monthly moving average Brainstorm Cell is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Brainstorm Cell by adding it to a well-diversified portfolio.
Brainstorm Cell Fundamentals Growth
Brainstorm Stock prices reflect investors' perceptions of the future prospects and financial health of Brainstorm Cell, and Brainstorm Cell fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Brainstorm Stock performance.
| Return On Equity | -11.22 | ||||
| Return On Asset | -1.78 | ||||
| Current Valuation | 12.25 M | ||||
| Shares Outstanding | 5.7 M | ||||
| Price To Earning | (16.00) X | ||||
| Price To Book | 65.82 X | ||||
| EBITDA | (16.93 M) | ||||
| Net Income | (17.19 M) | ||||
| Cash And Equivalents | 12.24 M | ||||
| Cash Per Share | 0.34 X | ||||
| Total Debt | 672 K | ||||
| Debt To Equity | 0.60 % | ||||
| Current Ratio | 1.63 X | ||||
| Book Value Per Share | (1.21) X | ||||
| Cash Flow From Operations | (20.46 M) | ||||
| Earnings Per Share | (3.45) X | ||||
| Market Capitalization | 10.89 M | ||||
| Total Asset | 4.21 M | ||||
| Retained Earnings | (215.01 M) | ||||
| Working Capital | (5.69 M) | ||||
| Current Asset | 16.79 M | ||||
| Current Liabilities | 2.95 M | ||||
About Brainstorm Cell Performance
By evaluating Brainstorm Cell's fundamental ratios, stakeholders can gain valuable insights into Brainstorm Cell's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Brainstorm Cell has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Brainstorm Cell has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (3.68) | (3.86) | |
| Return On Capital Employed | 5.37 | 5.64 | |
| Return On Assets | (3.68) | (3.86) | |
| Return On Equity | 3.19 | 3.34 |
Things to note about Brainstorm Cell Ther performance evaluation
Checking the ongoing alerts about Brainstorm Cell for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Brainstorm Cell Ther help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Brainstorm Cell Ther had very high historical volatility over the last 90 days | |
| Brainstorm Cell Ther may become a speculative penny stock | |
| Brainstorm Cell Ther has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (17.19 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Brainstorm Cell Therapeutics currently holds about 12.24 M in cash with (20.46 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.34. | |
| Brainstorm Cell Ther has a poor financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Brainstorm Cell Therapeutics Appeals Nasdaq Delisting - MSN |
- Analyzing Brainstorm Cell's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Brainstorm Cell's stock is overvalued or undervalued compared to its peers.
- Examining Brainstorm Cell's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Brainstorm Cell's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Brainstorm Cell's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Brainstorm Cell's stock. These opinions can provide insight into Brainstorm Cell's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Brainstorm Stock analysis
When running Brainstorm Cell's price analysis, check to measure Brainstorm Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainstorm Cell is operating at the current time. Most of Brainstorm Cell's value examination focuses on studying past and present price action to predict the probability of Brainstorm Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainstorm Cell's price. Additionally, you may evaluate how the addition of Brainstorm Cell to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |